Document Detail

Twin-twin transfusion syndrome.
MedLine Citation:
PMID:  23200164     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: We sought to review the natural history, pathophysiology, diagnosis, and treatment options for twin-twin transfusion syndrome (TTTS).
METHODS: A systematic review was performed using MEDLINE database, PubMed, EMBASE, and Cochrane Library. The search was restricted to English-language articles published from 1966 through July 2012. Priority was given to articles reporting original research, in particular randomized controlled trials, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Evidence reports and guidelines published by organizations or institutions such as the National Institutes of Health, Agency for Health Research and Quality, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine were also reviewed, and additional studies were located by reviewing bibliographies of identified articles. Consistent with US Preventive Task Force guidelines, references were evaluated for quality based on the highest level of evidence, and recommendations were graded accordingly.
RESULTS AND RECOMMENDATIONS: TTTS is a serious condition that can complicate 8-10% of twin pregnancies with monochorionic diamniotic (MCDA) placentation. The diagnosis of TTTS requires 2 criteria: (1) the presence of a MCDA pregnancy; and (2) the presence of oligohydramnios (defined as a maximal vertical pocket of <2 cm) in one sac, and of polyhydramnios (a maximal vertical pocket of >8 cm) in the other sac. The Quintero staging system appears to be a useful tool for describing the severity of TTTS in a standardized fashion. Serial sonographic evaluation should be considered for all twins with MCDA placentation, usually beginning at around 16 weeks and continuing about every 2 weeks until delivery. Screening for congenital heart disease is warranted in all monochorionic twins, in particular those complicated by TTTS. Extensive counseling should be provided to patients with pregnancies complicated by TTTS including natural history of the disease, as well as management options and their risks and benefits. The natural history of stage I TTTS is that more than three-fourths of cases remain stable or regress without invasive intervention, with perinatal survival of about 86%. Therefore, many patients with stage I TTTS may often be managed expectantly. The natural history of advanced (eg, stage ≥III) TTTS is bleak, with a reported perinatal loss rate of 70-100%, particularly when it presents <26 weeks. Fetoscopic laser photocoagulation of placental anastomoses is considered by most experts to be the best available approach for stages II, III, and IV TTTS in continuing pregnancies at <26 weeks, but the metaanalysis data show no significant survival benefit, and the long-term neurologic outcomes in the Eurofetus trial were not different than in nonlaser-treated controls. Even laser-treated TTTS is associated with a perinatal mortality rate of 30-50%, and a 5-20% chance of long-term neurologic handicap. Steroids for fetal maturation should be considered at 24 0/7 to 33 6/7 weeks, particularly in pregnancies complicated by stage ≥III TTTS, and those undergoing invasive interventions.
; Lynn L Simpson
Related Documents :
11790084 - Solvolysis of vinyl iodonium salts. new insights into vinyl cation intermediates.
10615844 - Fetal antigen hypothesis and ovarian cancer: is there an immunogenic explanation for th...
25077474 - Selective reduction in complex monochorionic gestations.
24102884 - Associations for birthweight of twin pairs in south india.
11306234 - Screening for bacterial vaginosis in pregnancy.
8198224 - Effect of ethanol on insulin-like growth factor-ii release from fetal organs.
Publication Detail:
Type:  Journal Article; Practice Guideline     Date:  2012-11-27
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  208     ISSN:  1097-6868     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-24     Completed Date:  2013-02-22     Revised Date:  2013-09-18    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3-18     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2013 Mosby, Inc. All rights reserved.
Society for Maternal-Fetal Medicine Publications Committee, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fetofetal Transfusion / diagnosis*,  etiology,  therapy
Pregnancy, Twin*
Prenatal Diagnosis / methods*
Comment In:
Am J Obstet Gynecol. 2013 Aug;209(2):159-60   [PMID:  23524171 ]
Am J Obstet Gynecol. 2013 Aug;209(2):157-8   [PMID:  23524169 ]
Am J Obstet Gynecol. 2013 Aug;209(2):158   [PMID:  23524172 ]
Am J Obstet Gynecol. 2013 Aug;209(2):158-9   [PMID:  23524174 ]
Erratum In:
Am J Obstet Gynecol. 2013 May;208(5):392

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Protective behavioral strategies as a mediator of the generalized anxiety and alcohol use relationsh...
Next Document:  Idiopathic macular telangiectasia: Clinical appearance, imaging and treatment.